Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
87
Employees87
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
87
Employees87

CELC Key Statistics

Market cap
4.89B
Market cap4.89B
Price-Earnings ratio
-28.51
Price-Earnings ratio-28.51
Dividend yield
Dividend yield
Average volume
628.59K
Average volume628.59K
High today
$105.65
High today$105.65
Low today
$103.47
Low today$103.47
Open price
$104.41
Open price$104.41
Volume
197.65K
Volume197.65K
52 Week high
$112.64
52 Week high$112.64
52 Week low
$7.58
52 Week low$7.58

Stock Snapshot

With a market cap of 4.89B, Celcuity(CELC) trades at $105.65. The stock has a price-to-earnings ratio of -28.51.

During the trading session on 2026-01-09, Celcuity(CELC) shares reached a daily high of $105.65 and a low of $103.47. At a current price of $105.65, the stock is +2.1% higher than the low and still 0.0% under the high.

Trading activity shows a volume of 197.65K, compared to an average daily volume of 628.59K.

Over the past 52 weeks, Celcuity(CELC) stock has traded between a high of $112.64 and a low of $7.58.

Over the past 52 weeks, Celcuity(CELC) stock has traded between a high of $112.64 and a low of $7.58.

CELC News

Simply Wall St 4d
How Gedatolisib’s Phase 3 Outcomes At Celcuity Have Changed Its Investment Story

In 2025, Celcuity reported past phase 3 trial results showing its breast cancer candidate gedatolisib, combined with palbociclib and fulvestrant, extended cance...

How Gedatolisib’s Phase 3 Outcomes At Celcuity Have Changed Its Investment Story

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.